These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 12865452)

  • 1. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.
    Strickler HD; Palefsky JM; Shah KV; Anastos K; Klein RS; Minkoff H; Duerr A; Massad LS; Celentano DD; Hall C; Fazzari M; Cu-Uvin S; Bacon M; Schuman P; Levine AM; Durante AJ; Gange S; Melnick S; Burk RD
    J Natl Cancer Inst; 2003 Jul; 95(14):1062-71. PubMed ID: 12865452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).
    Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G
    Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts.
    Silverberg MJ; Ahdieh L; Munoz A; Anastos K; Burk RD; Cu-Uvin S; Duerr A; Greenblatt RM; Klein RS; Massad S; Minkoff H; Muderspach L; Palefsky J; Piessens E; Schuman P; Watts H; Shah KV
    Sex Transm Dis; 2002 Aug; 29(8):427-35. PubMed ID: 12172526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women.
    Vernon SD; Reeves WC; Clancy KA; Laga M; St Louis M; Gary HE; Ryder RW; Manoka AT; Icenogle JP
    J Infect Dis; 1994 May; 169(5):1108-12. PubMed ID: 8169402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological evidence that common HPV types may be common because of their ability to evade immune surveillance: Results from the Women's Interagency HIV study.
    Castle PE; Burk RD; Massad LS; Eltoum IE; Hall CB; Hessol NA; Anastos K; Xie X; Minkoff H; Xue X; D'Souza G; Flowers L; Colie C; Rahangdale L; Fischl MA; Palefsky JM; Strickler HD
    Int J Cancer; 2020 Jun; 146(12):3320-3328. PubMed ID: 31577842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status.
    Garzetti GG; Ciavattini A; Butini L; Vecchi A; Montroni M
    Gynecol Obstet Invest; 1995; 40(1):52-6. PubMed ID: 7557645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection in women infected with the human immunodeficiency virus.
    Sun XW; Kuhn L; Ellerbrock TV; Chiasson MA; Bush TJ; Wright TC
    N Engl J Med; 1997 Nov; 337(19):1343-9. PubMed ID: 9358128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.
    Spinillo A; Debiaggi M; Zara F; De Santolo A; Polatti F; Filice G
    Obstet Gynecol; 2001 Jun; 97(6):999-1004. PubMed ID: 11384710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women.
    Tornesello ML; Duraturo ML; Giorgi-Rossi P; Sansone M; Piccoli R; Buonaguro L; Buonaguro FM
    J Gen Virol; 2008 Jun; 89(Pt 6):1380-1389. PubMed ID: 18474553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy.
    Eckert LO; Watts DH; Koutsky LA; Hawes SE; Stevens CE; Kuypers J; Kiviat NB
    Infect Dis Obstet Gynecol; 1999; 7(3):158-64. PubMed ID: 10371475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitype Infections With Human Papillomavirus: Impact of Human Immunodeficiency Virus Coinfection.
    Massad L; Keller M; Xie X; Minkoff H; Palefsky J; DʼSouza G; Colie C; Villacres M; Strickler H
    Sex Transm Dis; 2016 Oct; 43(10):637-41. PubMed ID: 27631359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.
    Williams AB; Darragh TM; Vranizan K; Ochia C; Moss AR; Palefsky JM
    Obstet Gynecol; 1994 Feb; 83(2):205-11. PubMed ID: 8290181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.
    Palefsky JM; Minkoff H; Kalish LA; Levine A; Sacks HS; Garcia P; Young M; Melnick S; Miotti P; Burk R
    J Natl Cancer Inst; 1999 Feb; 91(3):226-36. PubMed ID: 10037100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of oncogenic human papillomavirus in the genital tract of women with human immunodeficiency virus.
    Volkow P; Rubí S; Lizano M; Carrillo A; Vilar-Compte D; García-Carrancá A; Sotelo R; García B; Sierra-Madero J; Mohar A
    Gynecol Oncol; 2001 Jul; 82(1):27-31. PubMed ID: 11426958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women.
    Schlecht NF; Burk RD; Palefsky JM; Minkoff H; Xue X; Massad LS; Bacon M; Levine AM; Anastos K; Gange SJ; Watts DH; Costa MMD; Chen Z; Bang JY; Fazzari M; Hall C; Strickler HD
    J Gen Virol; 2005 Oct; 86(Pt 10):2709-2720. PubMed ID: 16186224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women.
    Petter A; Heim K; Guger M; Ciresa-Kö Nig A; Christensen N; Sarcletti M; Wieland U; Pfister H; Zangerle R; Höpfl R
    J Gen Virol; 2000 Mar; 81(Pt 3):701-8. PubMed ID: 10675407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy.
    Richter KL; van Rensburg EJ; van Heerden WF; Boy SC
    J Oral Pathol Med; 2008 Oct; 37(9):555-9. PubMed ID: 18355174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.